icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
The Combination of Elbasvir and Grazoprevir ± RBV Is Highly Effective for the Treatment of GT1a-Infected Patients
 
 
  Reported by Jules Levin
Presented at
AASLD - The Liver Meeting 2015®;
November 13-17, 2015;
San Francisco, CA, USA.
 
Thompson A1; Zeuzem S2; Rockstroh J3; Kwo P4; Roth D5; Lawitz E6; Sulkowski M7; Forns X8; Wahl J9; Nguyen B-Y9; Barr E9; Howe A9*; Miller M9; Hwang P9; Robertson MN9
 
1University of Melbourne, Department of Medicine, Melbourne, Australia; 2Goethe University Hospital, Frankfurt, Germany; 3Bonn University Hospital, Bonn, Germany; 4Indiana University School of Medicine, Indianapolis, IN, USA; 5University of Miami Miller School of Medicine, Miami, FL, USA; 6The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX, USA; 7Johns Hopkins University School of Medicine, Baltimore, MD, USA; 8Liver Unit, Hospital Clinic, IDIBAPS and CIBEREHD, Barcelona, Spain; 9Merck & Co., Inc., Kenilworth, NJ, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif